Host factor prioritization for pan-viral genetic perturbation screens using random intercept models and network propagation.


Journal

PLoS computational biology
ISSN: 1553-7358
Titre abrégé: PLoS Comput Biol
Pays: United States
ID NLM: 101238922

Informations de publication

Date de publication:
02 2020
Historique:
received: 27 06 2019
accepted: 05 12 2019
revised: 21 02 2020
pubmed: 11 2 2020
medline: 28 5 2020
entrez: 11 2 2020
Statut: epublish

Résumé

Genetic perturbation screens using RNA interference (RNAi) have been conducted successfully to identify host factors that are essential for the life cycle of bacteria or viruses. So far, most published studies identified host factors primarily for single pathogens. Furthermore, often only a small subset of genes, e.g., genes encoding kinases, have been targeted. Identification of host factors on a pan-pathogen level, i.e., genes that are crucial for the replication of a diverse group of pathogens has received relatively little attention, despite the fact that such common host factors would be highly relevant, for instance, for devising broad-spectrum anti-pathogenic drugs. Here, we present a novel two-stage procedure for the identification of host factors involved in the replication of different viruses using a combination of random effects models and Markov random walks on a functional interaction network. We first infer candidate genes by jointly analyzing multiple perturbations screens while at the same time adjusting for high variance inherent in these screens. Subsequently the inferred estimates are spread across a network of functional interactions thereby allowing for the analysis of missing genes in the biological studies, smoothing the effect sizes of previously found host factors, and considering a priori pathway information defined over edges of the network. We applied the procedure to RNAi screening data of four different positive-sense single-stranded RNA viruses, Hepatitis C virus, Chikungunya virus, Dengue virus and Severe acute respiratory syndrome coronavirus, and detected novel host factors, including UBC, PLCG1, and DYRK1B, which are predicted to significantly impact the replication cycles of these viruses. We validated the detected host factors experimentally using pharmacological inhibition and an additional siRNA screen and found that some of the predicted host factors indeed influence the replication of these pathogens.

Identifiants

pubmed: 32040506
doi: 10.1371/journal.pcbi.1007587
pii: PCOMPBIOL-D-19-01066
pmc: PMC7034926
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1007587

Déclaration de conflit d'intérêts

Enter: The authors have declared that no competing interests exist.

Références

Antimicrob Agents Chemother. 2013 Oct;57(10):4971-81
pubmed: 23896472
PLoS Pathog. 2015 Jan 08;11(1):e1004573
pubmed: 25569684
Bioinformatics. 2018 Jul 15;34(14):2441-2448
pubmed: 29547932
Bacteriol Rev. 1971 Sep;35(3):235-41
pubmed: 4329869
Nat Immunol. 2009 Aug;10(8):799-804
pubmed: 19621037
BMC Genomics. 2009 May 12;10:220
pubmed: 19435510
Cell Rep. 2016 Jun 28;16(1):232-246
pubmed: 27342126
Antiviral Res. 2014 Oct;110:20-30
pubmed: 25046486
Nat Rev Clin Oncol. 2017 Jul;14(7):417-433
pubmed: 28117417
Nat Methods. 2007 Oct;4(10):847-9
pubmed: 17828270
J Virol. 2003 Aug;77(15):8181-6
pubmed: 12857886
BMC Genomics. 2014 Dec 22;15:1162
pubmed: 25534632
Stat Appl Genet Mol Biol. 2019 Mar 6;18(3):
pubmed: 30840598
Nature. 2016 Jul 7;535(7610):159-63
pubmed: 27383987
World J Virol. 2013 May 12;2(2):18-31
pubmed: 24175227
Cell Rep. 2019 May 28;27(9):2579-2592.e6
pubmed: 31141684
Nat Rev Genet. 2015 Jan;16(1):18-32
pubmed: 25446316
Nat Biotechnol. 2006 May;24(5):537-44
pubmed: 16680138
Nat Biotechnol. 2003 Jun;21(6):635-7
pubmed: 12754523
Nat Methods. 2006 Mar;3(3):199-204
pubmed: 16489337
Nat Rev Mol Cell Biol. 2011 Feb;12(2):119-25
pubmed: 21224886
Cell Host Microbe. 2011 Jan 20;9(1):32-45
pubmed: 21238945
Nat Commun. 2016 May 12;7:11320
pubmed: 27177310
Nature. 2002 Jul 11;418(6894):244-51
pubmed: 12110901
Gastroenterology. 2015 Mar;148(3):616-25
pubmed: 25479136
RNA Biol. 2011 Mar-Apr;8(2):258-69
pubmed: 21593584
Cell Host Microbe. 2011 Jan 20;9(1):70-82
pubmed: 21238948
Genome Biol. 2006;7(7):R66
pubmed: 16869968
Genome Biol. 2015 Oct 07;16:220
pubmed: 26445817
J Virol. 2015 Aug;89(16):8318-33
pubmed: 26041291
Nature. 2016 Jul 7;535(7610):164-8
pubmed: 27383988
IEEE/ACM Trans Comput Biol Bioinform. 2013 Mar-Apr;10(2):423-35
pubmed: 23929866
Nat Cell Biol. 2009 May;11(5):527-34
pubmed: 19404332
Antiviral Res. 2015 Aug;120:48-56
pubmed: 26001632
Genome Biol. 2010;11(5):R53
pubmed: 20482850
Cell Cycle. 2007 Apr 15;6(8):898-901
pubmed: 17438372
PLoS Pathog. 2016 Oct 27;12(10):e1005912
pubmed: 27788266
Adv Biol Regul. 2017 Jan;63:92-97
pubmed: 27707630
Nat Rev Genet. 2017 Sep;18(9):551-562
pubmed: 28607512
Algorithms Mol Biol. 2015 Feb 13;10:6
pubmed: 25691914
Nat Methods. 2009 Aug;6(8):569-75
pubmed: 19644458
Nat Rev Genet. 2008 Jul;9(7):554-66
pubmed: 18521077
Hepatol Res. 2019 May;49(5):559-569
pubmed: 30623526
Nature. 2009 Sep 24;461(7263):520-3
pubmed: 19710653
J Biomol Screen. 2007 Jun;12(4):497-509
pubmed: 17435171

Auteurs

Simon Dirmeier (S)

Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
SIB Swiss Institute of Bioinformatics, Basel, Switzerland.

Christopher Dächert (C)

Research Group "Dynamics of Early Viral Infection and the Innate Antiviral Response" (division F170), German Cancer Research Center, Heidelberg, Germany.
Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.

Martijn van Hemert (M)

Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.

Ali Tas (A)

Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.

Natacha S Ogando (NS)

Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.

Frank van Kuppeveld (F)

Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.

Ralf Bartenschlager (R)

Department for Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
Division Virus-Associated Carcinogenesis, German Cancer Research Center, Heidelberg, Germany.

Lars Kaderali (L)

University Medicine Greifswald, Institute of Bioinformatics, Greifswald, Germany.

Marco Binder (M)

Research Group "Dynamics of Early Viral Infection and the Innate Antiviral Response" (division F170), German Cancer Research Center, Heidelberg, Germany.

Niko Beerenwinkel (N)

Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
SIB Swiss Institute of Bioinformatics, Basel, Switzerland.

Articles similaires

High-throughput Bronchus-on-a-Chip system for modeling the human bronchus.

Akina Mori, Marjolein Vermeer, Lenie J van den Broek et al.
1.00
Humans Bronchi Lab-On-A-Chip Devices Epithelial Cells Goblet Cells
Animals Lung India Sheep Transcriptome
1.00
Algorithms Computer Simulation Models, Biological Programming Languages Humans
Spliceosomes Humans Transcriptome Alternative Splicing RNA Splice Sites

Classifications MeSH